Cyclophosphamide

CD8a molecule ; Homo sapiens







29 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33268528 Cyclophosphamide and Vinorelbine Activate Stem-Like CD8+ T Cells and Improve Anti-PD-1 Efficacy in Triple-Negative Breast Cancer. 2021 Feb 1 1
2 33897897 Genetic engineering cellular vesicles expressing CD64 as checkpoint antibody carrier for cancer immunotherapy. 2021 1
3 34224377 Correction: Cyclophosphamide and Vinorelbine Activate Stem-Like CD8+ T Cells and Improve Anti-PD-1 Efficacy in Triple-Negative Breast Cancer. 2021 Jun 15 1
4 30262565 T-cell receptor-α repertoire of CD8+ T cells following allogeneic stem cell transplantation using next-generation sequencing. 2019 Mar 1
5 31143518 A novel combination of chemotherapy and immunotherapy controls tumor growth in mice with a human immune system. 2019 1
6 30063143 Engineering PD-1-Presenting Platelets for Cancer Immunotherapy. 2018 Sep 12 1
7 28132769 Immunosuppression in sheep induced by cyclophosphamide, bluetongue virus and their combination: Effect on clinical reaction and viremia. 2017 Mar 1
8 28815584 Maintenance of CD8+ memory T lymphocytes in the spleen but not in the bone marrow is dependent on proliferation. 2017 Nov 1
9 29114880 Maintenance of memory CD8 T cells: Divided over division. 2017 Nov 1
10 27980738 Mature CD8+ T-cell clonal expansion in the oral cavity and digestive tract: a severe lymphoid malignancy that mimics Crohn's disease. 2016 Dec 1
11 26041539 Critical Roles of Chemoresistant Effector and Regulatory T Cells in Antitumor Immunity after Lymphodepleting Chemotherapy. 2015 Jul 15 1
12 23507054 Infections in vasculitis. 2013 Feb 1
13 22285846 Cyclophosphamide inhibits the generation and function of CD8(+) regulatory T cells. 2012 Mar 2
14 22539294 Double negative Treg cells promote nonmyeloablative bone marrow chimerism by inducing T-cell clonal deletion and suppressing NK cell function. 2012 May 1
15 22720230 Colon cancer eradication after chemoimmunotherapy is associated with intratumoral emergence of proinflammatory myeloid cells. 2012 Jan 1 1
16 20857100 Fludarabine modulates composition and function of the T cell pool in patients with chronic lymphocytic leukaemia. 2011 Jan 1
17 21908423 A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigens. 2011 Nov 3 1
18 18410892 The allogeneic effect revisited: exogenous help for endogenous, tumor-specific T cells. 2008 May 1
19 17198082 Defining the ability of cyclophosphamide preconditioning to enhance the antigen-specific CD8+ T-cell response to peptide vaccination: creation of a beneficial host microenvironment involving type I IFNs and myeloid cells. 2007 Jan 1
20 14698862 Cyclophosphamide modulates CD4+ T cells into a T helper type 2 phenotype and reverses increased IFN-gamma production of CD8+ T cells in secondary progressive multiple sclerosis. 2004 Jan 3
21 11347331 Clinico-laboratory study of methylprednisolone and cyclophosphamide treatment in patients with multiple sclerosis relapse. 2000 1
22 8844499 Intravenous cyclophosphamide combined with methylprednisolone in the treatment of severe refractory rheumatoid arthritis: the effect on lymphocytes. 1996 Jul-Aug 1
23 7751644 Recruitment and proliferation of CD8+ T cells in respiratory virus infections. 1995 Jun 1 2
24 8231237 Cyclophosphamide treatment of an SJL murine B-cell lymphoma increases the proportion of suppressive CD8+ over tumor-stimulatory CD4+ T-lymphocytes. 1993 Nov 2
25 1672870 Immunologic effects of cyclophosphamide/ACTH in patients with chronic progressive multiple sclerosis. 1991 May 1
26 1766265 Remission of monoclonal chronic T-cell expansion associated with severe anemia. 1991 1
27 2145216 Elimination of cycling CD4+ suppressor T cells with an anti-mitotic drug releases non-cycling CD8+ T cells to cause regression of an advanced lymphoma. 1990 Sep 3
28 2787959 Marrow hypoplasia associated with a monoclonal CD8 large granular lymphocyte proliferation: reversal with cyclophosphamide and prednisone. 1989 Aug 1
29 2960008 Effects of immunosuppressive agents and particularly of cyclophosphamide on lymphocytes subsets in treated multiple sclerosis patients. 1987 May-Jun 1